SCHEMBL6990056

SCHEMBL6990056

CC1OCC(=O)C1(C)NC(=O)C(CNC(=O)c1ccc(C(F)(F)F)cc1)c1ccc(O)cc1

nearest known ligand 0.37

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 1/20 0.37
OPRD1 P41143 1/20 0.37
TRPM8 Q7Z2W7 1/20 0.35
BACE1 P56817 1/20 0.35
PTGER4 P35408 4/20 0.34
LMNA P02545 1/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34
TSHR P16473 1/20 0.34
CYP2C19 P33261 1/20 0.34
PDE2A O00408 2/20 0.33
POLB P06746 1/20 0.33
HDAC4 P56524 2/20 0.33
HDAC6 Q9UBN7 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6989542 0.92 TP53 (0.40) LMNAALDH1A1POLB
SCHEMBL6987871 0.90 CTSK (0.39) LMNAALDH1A1PDE2A
SCHEMBL6981853 0.90 TRPV1 (0.42)
SCHEMBL6990344 0.90 MEN1 (0.37) OPRM1OPRD1BACE1LMNAPDE2A
SCHEMBL6988403 0.89 KMT2A (0.35) OPRM1OPRD1LMNAALDH1A1CYP3A4
SCHEMBL6990082 0.88 MAPT (0.41) LMNAALDH1A1POLB
SCHEMBL6988694 0.87 ATM (0.39) LMNAALDH1A1PDE2APOLB
SCHEMBL6988433 0.87 TAS1R3 (0.35)
SCHEMBL6988884 0.85 CTSS (0.36) OPRM1OPRD1ALDH1A1HDAC6
SCHEMBL6985501 0.82 GCGR (0.41) PDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1362042-A1 CYCLIC 2-CARBONYLAMINOKETONES AS INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES Amura Therapeutics Limited (GB) 2003-11-19 EP disclosed
WO-2002057249-A1 CYCLIC 2-CARBONYLAMINOKETONES AS INHIBITORS OF CRUZIPAIN AND OTHER CYSTEINE PROTEASES AMURA THERAPEUTICS LIMITED (GB) 2002-07-25 WO disclosed